Literature DB >> 19574646

Protein preparation, crystallization and preliminary crystallographic studies of Bacillus subtilis glycinamide ribonucleotide transformylase.

Yu-He Liang1, Xiang-Yu Liu, Juan Wang, Lan-Fen Li.   

Abstract

Glycinamide ribonucleotide transformylase (GART) catalyzes the transfer of a formyl group from formyl tetrahydrofolate (FTHF) to glycinamide ribonucleotide (GAR), which is an essential step in the de novo synthesis pathway of purines. In Bacillus subtilis, GART is encoded by the gene purN. In order to study the structure and function of B. subtilis GART, the purN gene was amplified, cloned into an expression vector and expressed in soluble form in Escherichia coli. The protein was purified to homogeneity and crystals suitable for X-ray data collection were obtained. These crystals diffracted to 2.5 A resolution and belonged to space group P3(1)21, with unit-cell parameters a = b = 95.5, c = 64.0 A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19574646      PMCID: PMC2705641          DOI: 10.1107/S1744309109020703

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  25 in total

1.  A role for a highly conserved protein of unknown function in regulation of Bacillus subtilis purA by the purine repressor.

Authors:  P Rappu; B S Shin; H Zalkin; P Mäntsälä
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

2.  Rational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid.

Authors:  Yan Zhang; Joel Desharnais; Thomas H Marsilje; Chenglong Li; Michael P Hedrick; Lata T Gooljarsingh; Ali Tavassoli; Stephen J Benkovic; Arthur J Olson; Dale L Boger; Ian A Wilson
Journal:  Biochemistry       Date:  2003-05-27       Impact factor: 3.162

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

4.  The human glycinamide ribonucleotide transformylase domain: purification, characterization, and kinetic mechanism.

Authors:  C A Caperelli; E L Giroux
Journal:  Arch Biochem Biophys       Date:  1997-05-01       Impact factor: 4.013

5.  Unexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase.

Authors:  S E Greasley; T H Marsilje; H Cai; S Baker; S J Benkovic; D L Boger; I A Wilson
Journal:  Biochemistry       Date:  2001-11-13       Impact factor: 3.162

6.  Cloning and characterization of a 12-gene cluster from Bacillus subtilis encoding nine enzymes for de novo purine nucleotide synthesis.

Authors:  D J Ebbole; H Zalkin
Journal:  J Biol Chem       Date:  1987-06-15       Impact factor: 5.157

7.  The apo and ternary complex structures of a chemotherapeutic target: human glycinamide ribonucleotide transformylase.

Authors:  Tanya E S Dahms; Germaine Sainz; Eugene L Giroux; Carol A Caperelli; Janet L Smith
Journal:  Biochemistry       Date:  2005-07-26       Impact factor: 3.162

8.  Proton transfer dynamics of GART: the pH-dependent catalytic mechanism examined by electrostatic calculations.

Authors:  D Morikis; A H Elcock; P A Jennings; J A McCammon
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

9.  Crystal structure of glycinamide ribonucleotide transformylase from Escherichia coli at 3.0 A resolution. A target enzyme for chemotherapy.

Authors:  P Chen; U Schulze-Gahmen; E A Stura; J Inglese; D L Johnson; A Marolewski; S J Benkovic; I A Wilson
Journal:  J Mol Biol       Date:  1992-09-05       Impact factor: 5.469

10.  Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 A resolution.

Authors:  C Klein; P Chen; J H Arevalo; E A Stura; A Marolewski; M S Warren; S J Benkovic; I A Wilson
Journal:  J Mol Biol       Date:  1995-05-26       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.